<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">J Am Heart Assoc</journal-id><journal-id journal-id-type="iso-abbrev">J Am Heart Assoc</journal-id><journal-id journal-id-type="hwp">ahaoa</journal-id><journal-id journal-id-type="publisher-id">jah3</journal-id><journal-title-group><journal-title>Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease</journal-title></journal-title-group><issn pub-type="epub">2047-9980</issn><publisher><publisher-name>Blackwell Publishing Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">23525434</article-id><article-id pub-id-type="pmc">3603248</article-id><article-id pub-id-type="publisher-id">jah3169</article-id><article-id pub-id-type="doi">10.1161/JAHA.112.004309</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Research</subject><subj-group><subject>Vascular Medicine</subject></subj-group></subj-group></article-categories><title-group><article-title>Altered Nitric Oxide Bioavailability Contributes to Diesel Exhaust Inhalation&#x02010;Induced Cardiovascular Dysfunction in Man</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Langrish</surname><given-names>Jeremy P.</given-names></name><degrees>MRCP, PhD</degrees><xref ref-type="corresp" rid="cor1"/><xref ref-type="aff" rid="au1"/></contrib><contrib contrib-type="author"><name><surname>Unosson</surname><given-names>Jon</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="au2"/></contrib><contrib contrib-type="author"><name><surname>Bosson</surname><given-names>Jenny</given-names></name><degrees>MD, PhD</degrees><xref ref-type="aff" rid="au2"/></contrib><contrib contrib-type="author"><name><surname>Barath</surname><given-names>Stefan</given-names></name><degrees>MD, PhD</degrees><xref ref-type="aff" rid="au2"/></contrib><contrib contrib-type="author"><name><surname>Muala</surname><given-names>Ala</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="au2"/></contrib><contrib contrib-type="author"><name><surname>Blackwell</surname><given-names>Scott</given-names></name><degrees>PhD</degrees><xref ref-type="aff" rid="au3"/></contrib><contrib contrib-type="author"><name><surname>S&#x000f6;derberg</surname><given-names>Stefan</given-names></name><degrees>MD, PhD</degrees><xref ref-type="aff" rid="au4"/></contrib><contrib contrib-type="author"><name><surname>Pourazar</surname><given-names>Jamshid</given-names></name><degrees>PhD</degrees><xref ref-type="aff" rid="au2"/></contrib><contrib contrib-type="author"><name><surname>Megson</surname><given-names>Ian L.</given-names></name><degrees>PhD</degrees><xref ref-type="aff" rid="au5"/></contrib><contrib contrib-type="author"><name><surname>Treweeke</surname><given-names>Andrew</given-names></name><degrees>PhD</degrees><xref ref-type="aff" rid="au5"/></contrib><contrib contrib-type="author"><name><surname>Sandstr&#x000f6;m</surname><given-names>Thomas</given-names></name><degrees>MD, PhD</degrees><xref ref-type="aff" rid="au2"/></contrib><contrib contrib-type="author"><name><surname>Newby</surname><given-names>David E.</given-names></name><degrees>DM, PhD</degrees><xref ref-type="aff" rid="au1"/></contrib><contrib contrib-type="author"><name><surname>Blomberg</surname><given-names>Anders</given-names></name><degrees>MD, PhD</degrees><xref ref-type="aff" rid="au2"/></contrib><contrib contrib-type="author"><name><surname>Mills</surname><given-names>Nicholas L.</given-names></name><degrees>MRCP, PhD</degrees><xref ref-type="aff" rid="au1"/></contrib><aff id="au1"><label>1</label><institution>University/British Heart Foundation Centre for Cardiovascular Science, University of Edinburgh, </institution><addr-line>Edinburgh, UK (J.P.L., D.E.N., N.L.M.)</addr-line></aff><aff id="au2"><label>2</label><institution>Department of Public Health and Clinical Medicine, Division of Medicine/Respiratory Medicine, Ume&#x000e5; University, </institution><addr-line>Ume&#x000e5;, Sweden (J.U., J.B., S.B., A.M., J.P., T.S., A.B.)</addr-line></aff><aff id="au3"><label>3</label><institution>Department of Clinical Biochemistry, Royal Infirmary, </institution><addr-line>Glasgow, UK (S.B.)</addr-line></aff><aff id="au4"><label>4</label><institution>Department of Public Health and Clinical Medicine, Division of Medicine/Cardiology, Ume&#x000e5; University, </institution><addr-line>Ume&#x000e5;, Sweden (S.)</addr-line></aff><aff id="au5"><label>5</label><institution>Free Radical Research Facility, UHI Department of Diabetes and Cardiovascular Science, </institution><addr-line>Inverness, UK (I.L.M., A.T.)</addr-line></aff></contrib-group><author-notes><corresp id="cor1"><bold>Correspondence to:</bold> Jeremy P. Langrish, MRCP, PhD, Centre for Cardiovascular Sciences, University of Edinburgh, Room SU.305, Chancellor's Building, 49 Little France Crescent, Edinburgh, EH16 4SB, UK. E&#x02010;mail: <email>jeremy.langrish@ed.ac.uk</email></corresp><fn><p>An accompanying Data Supplement is available at <ext-link ext-link-type="uri" xlink:href="http://jaha.ahajournals.org/content/1/5/eXXXXXX.full">http://jaha.ahajournals.org/content/2/1/e004309.full</ext-link></p></fn></author-notes><pub-date pub-type="collection"><month>2</month><year>2013</year></pub-date><pub-date pub-type="epub"><day>22</day><month>2</month><year>2013</year></pub-date><volume>2</volume><issue>1</issue><elocation-id>e004309</elocation-id><history><date date-type="received"><day>28</day><month>8</month><year>2012</year></date><date date-type="accepted"><day>13</day><month>11</month><year>2012</year></date></history><permissions><copyright-statement>&#x000a9; 2013 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley-Blackwell.</copyright-statement><copyright-year>2013</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.5/"><license-p>This is an Open Access article under the terms of the Creative Commons Attribution Noncommercial License, which permits use, distribution, and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.</license-p></license></permissions><abstract><sec><title>Background</title><p>Diesel exhaust inhalation causes cardiovascular dysfunction including impaired vascular reactivity, increased blood pressure, and arterial stiffness. We investigated the role of nitric oxide (NO) bioavailability in mediating these effects.</p></sec><sec><title>Methods and Results</title><p>In 2 randomized double&#x02010;blind crossover studies, healthy nonsmokers were exposed to diesel exhaust or filtered air. <italic>Study 1</italic>: Bilateral forearm blood flow was measured during intrabrachial infusions of acetylcholine (ACh; 5 to 20 &#x003bc;g/min) and sodium nitroprusside (SNP; 2 to 8 &#x003bc;g/min) in the presence of the NO clamp (NO synthase inhibitor N<sup>G</sup>&#x02010;monomethyl&#x02010;l&#x02010;arginine (l&#x02010;NMMA) 8 &#x003bc;g/min coinfused with the NO donor SNP at 90 to 540 ng/min to restore basal blood flow). <italic>Study 2</italic>: Blood pressure, arterial stiffness, and cardiac output were measured during systemic NO synthase inhibition with intravenous l&#x02010;NMMA (3 mg/kg). Following diesel exhaust inhalation, plasma nitrite concentrations were increased (68&#x000b1;48 versus 41&#x000b1;32 nmol/L; <italic>P</italic>=0.006) despite similar l&#x02010;NMMA&#x02013;induced reductions in basal blood flow (&#x02212;20.6&#x000b1;14.7% versus &#x02212;21.1&#x000b1;14.6%; <italic>P</italic>=0.559) compared to air. In the presence of the NO clamp, ACh and SNP caused dose&#x02010;dependent vasodilatation that was not affected by diesel exhaust inhalation (<italic>P</italic>&#x0003e;0.05 for both). Following exposure to diesel exhaust, l&#x02010;NMMA caused a greater increase in blood pressure (<italic>P</italic>=0.048) and central arterial stiffness (<italic>P</italic>=0.007), but reductions in cardiac output and increases in systemic vascular resistance (<italic>P</italic>&#x0003e;0.05 for both) were similar to those seen with filtered air.</p></sec><sec><title>Conclusions</title><p>Diesel exhaust inhalation disturbs normal vascular homeostasis with enhanced NO generation unable to compensate for excess consumption. We suggest the adverse cardiovascular effects of air pollution are, in part, mediated through reduced NO bioavailability.</p></sec><sec><title>Clinical Trial Registration</title><p>URL: <ext-link ext-link-type="uri" xlink:href="http://www.ClinicalTrials.gov">http://www.ClinicalTrials.gov</ext-link>. Unique identifiers: NCT00845767 and NCT01060930.</p></sec></abstract><kwd-group><kwd>air pollution</kwd><kwd>endothelial function</kwd><kwd>nitric oxide</kwd><kwd>nitric oxide synthase</kwd><kwd>vascular biology</kwd></kwd-group></article-meta></front><body><sec><title>Introduction</title><p>Exposure to air pollution increases cardiovascular morbidity and mortality,<sup><xref ref-type="bibr" rid="b1">1</xref>&#x02013;<xref ref-type="bibr" rid="b4">4</xref></sup> and is associated with the triggering of acute myocardial infarction.<sup><xref ref-type="bibr" rid="b5">5</xref></sup> Recent controlled exposure studies in man have shown that inhalation of dilute diesel exhaust, at environmentally relevant concentrations, leads to an impairment of both vascular vasomotor and fibrinolytic function.<sup><xref ref-type="bibr" rid="b6">6</xref></sup> Similarly, exposure to concentrated ambient particles causes acute arterial vasoconstriction<sup><xref ref-type="bibr" rid="b7">7</xref></sup> and an increase in diastolic blood pressure.<sup><xref ref-type="bibr" rid="b8">8</xref></sup> Although providing plausible explanations for the increase in cardiovascular events,<sup><xref ref-type="bibr" rid="b9">9</xref></sup> the mechanisms of how air pollution induces these cardiovascular abnormalities remain to be established.</p><p>Inhalation of fine particulate matter causes inflammation within the lungs,<sup><xref ref-type="bibr" rid="b10">10</xref>&#x02013;<xref ref-type="bibr" rid="b11">11</xref></sup> in part, through local oxidative stress.<sup><xref ref-type="bibr" rid="b12">12</xref>&#x02013;<xref ref-type="bibr" rid="b13">13</xref></sup> Vascular oxidative stress may subsequently develop as a consequence of the systemic response to pulmonary inflammation and oxidative stress, or through reactive oxygen species generation within the vascular wall following translocation of particles into the circulation.<sup><xref ref-type="bibr" rid="b14">14</xref>&#x02013;<xref ref-type="bibr" rid="b15">15</xref></sup> Irrespective of the site of generation, it has been proposed that this oxidative stress has a direct influence on the function of the vascular endothelium<sup><xref ref-type="bibr" rid="b16">16</xref></sup> as well as reducing the vascular bioavailability of nitric oxide (NO).<sup><xref ref-type="bibr" rid="b6">6</xref>,<xref ref-type="bibr" rid="b17">17</xref></sup></p><p>NO is a powerful endogenous vasodilator and plays a crucial role in the maintenance of basal vascular tone.<sup><xref ref-type="bibr" rid="b18">18</xref></sup> In patients with pre&#x02010;existing vascular endothelial dysfunction, such as those with hypercholesterolemia, stimulated endothelium&#x02010;dependent NO&#x02010;mediated vasodilatation is impaired, and this is thought to be mediated through oxidative stress&#x02010;mediated depression of NO bioavailability.<sup><xref ref-type="bibr" rid="b19">19</xref></sup> In rats exposed to inhaled particles, the generation of oxygen&#x02010;centered free radicals leads to the scavenging of NO, thereby reducing its bioavailability.<sup><xref ref-type="bibr" rid="b20">20</xref></sup></p><p>In this study, we investigated the hypothesis that changes in NO bioavailability contribute to the cardiovascular dysfunction induced by diesel exhaust inhalation.</p></sec><sec sec-type="methods"><title>Methods</title><sec><title>Subjects</title><p>Thirty&#x02010;three healthy nonsmoking volunteers were recruited from the Department of Medicine, Division of Respiratory Medicine and Allergy, University Hospital, Ume&#x000e5;, Sweden. Subjects taking regular medication (excluding the oral contraceptive pill), with a significant occupational exposure to air pollution or those with intercurrent illness were excluded. All subjects were free of symptoms of respiratory tract infection for at least 6 weeks leading up to the study. The trial was performed with the approval of the local research ethics committee, in accordance with the Declaration of Helsinki, and with the written informed consent of each participant.</p></sec><sec><title>Diesel Exhaust Exposure</title><p>Diesel exhaust was generated using an idling Volvo diesel engine (Volvo TD40 GJE, 4.0 L, 4 cylinders, 680 rpm). Over 90% of the exhaust was shunted away, the remaining part diluted with high&#x02010;efficiency particulate air (HEPA) filtered air and fed into the exposure chamber at steady state concentration. During the exposure, air was sampled in the breathing zone of the subjects for oxides of nitrogen, particle mass concentration and total hydrocarbons (measured as propane). Filter samples were collected and analyzed gravimetrically to determine mass concentration. The exposures were standardized based on particulate matter (particles with a mean aerodynamic diameter &#x02264;10 &#x003bc;m [PM<sub>10</sub>]) concentrations and a mean airborne particle concentration of 313&#x000b1;11 &#x003bc;g/m<sup>3</sup> was generated. The particle exposure was associated with concentrations of nitrogen dioxide (NO<sub>2</sub>) of 0.9&#x000b1;0.1 ppm, NO of 3.1&#x000b1;0.2 ppm and total hydrocarbons of 2.5&#x000b1;0.2 ppm. Temperature and humidity in the chamber were controlled at 22&#x000b0;C and 50%, respectively.</p></sec><sec><title>Study Design</title><p>Subjects attended on 2 occasions at least 1 week apart. In 2 randomized double&#x02010;blind crossover studies, subjects were exposed to either filtered air or dilute diesel exhaust at &#x02248;300 &#x003bc;g/m<sup>3</sup> in a specially built diesel exposure chamber as described previously.<sup><xref ref-type="bibr" rid="b21">21</xref></sup> During the exposures, subjects performed 15&#x02010;minute periods of exercise on a bicycle ergometer, to achieve a mean minute ventilation of 20 L/min per m<sup>2</sup> as determined by a prestudy exercise test, alternating with 15 minutes of rest.</p><p>Based on previous studies, vascular assessments were performed 2 hours after the exposure.<sup><xref ref-type="bibr" rid="b6">6</xref>,<xref ref-type="bibr" rid="b22">22</xref></sup> All subjects abstained from alcohol for 24 hours, caffeinated drinks for 8 hours and food for 4 hours prior to the cardiovascular assessments, and remained indoors between the exposure and assessments to minimize additional exposure to air pollution. Venous blood samples were collected for measurement of plasma nitrite concentration, endogenous NOS inhibitors, and total and differential cell counts. Lung function was determined by spirometry at baseline and 2 hours following the exposure (Jaeger Masterlab, Jaeger AG) recording forced vital capacity (FVC), forced expiratory volume in 1 second (FEV<sub>1</sub>), and slow vital capacity (VC).</p></sec><sec><title>Study 1: Local NO Synthase Inhibition</title><p>Eighteen subjects were recruited into this study. Forearm blood flow was determined using forearm venous occlusion plethysmography and detected using mercury&#x02010;in&#x02010;silastic strain gauges placed around each forearm as described previously.<sup><xref ref-type="bibr" rid="b23">23</xref></sup> All subjects underwent unilateral brachial artery cannulation using a 27&#x02010;gauge steel needle (Coopers Needle Works Ltd) under controlled conditions. After a 30&#x02010;min baseline infusion of 0.9% saline, subjects received an infusion of the NO synthase (NOS) inhibitor N<sup>G</sup>&#x02010;monomethyl&#x02010;l&#x02010;arginine (l&#x02010;NMMA; Clinalfa<sup>&#x000ae;</sup> basic, Bachem) at incremental doses of 2, 4, and 8 &#x003bc;mol/min. The infusion of l&#x02010;NMMA was continued at 8 &#x003bc;mol/min for the remainder of the study to fully inhibit all basal NOS activity.<sup><xref ref-type="bibr" rid="b24">24</xref>&#x02013;<xref ref-type="bibr" rid="b25">25</xref></sup> Sodium nitroprusside (SNP), an NO donor, was then coinfused with l&#x02010;NMMA at doses of 90 to 540 ng/min and titrated to restore basal blood flow. Once basal blood flow was restored, the SNP infusion was continued for the remainder of the study to produce an &#x0201c;NO clamp&#x0201d; as described previously.<sup><xref ref-type="bibr" rid="b24">24</xref></sup> This permits the assessment of vascular function in the absence of endogenous NO generation but without the potential confounding effects of basal vasoconstriction induced by isolated NO synthase inhibition.</p><p>The dose&#x02010;response relationship of the vasodilators acetylcholine (5, 10, and 20 &#x003bc;g/min<sup><xref ref-type="bibr" rid="b6">6</xref></sup>; endothelium&#x02010;dependent NO donor) and SNP (2, 4, and 8 &#x003bc;g/min<sup><xref ref-type="bibr" rid="b6">6</xref></sup>; endothelium&#x02010;independent NO donor) were assessed in the presence of the clamp. The vasodilators were given in a random order and were separated by an infusion of 0.9% saline for 20 minutes. The combined total infusion rate of the parallel infusions was kept constant at 1 mL/min throughout the study.</p></sec><sec><title>Study 2: Systemic Nitric Oxide Synthase Inhibition</title><p>Fifteen subjects were recruited into this study. Subjects had a 20&#x02010;gauge arterial line inserted to the radial artery of the non&#x02010;dominant arm (Leader&#x02010;Cath, Vygon SA). The arterial catheter was attached to a validated pressure transducer (Deltran<sup>&#x000ae;</sup> II, Utah Medical Products) and data were recorded in real&#x02010;time using Powerlab instruments and LabChart software (AD Instruments Pty Ltd). A validated semi&#x02010;automatic oscillometric sphygmomanometer was placed around the upper arm of the dominant arm. Cardiac output, peripheral resistance, and stroke index were recorded using thoracic bioimpedence (Hotman<sup>&#x000ae;</sup>, Hemo Sapiens, Inc) and central arterial stiffness (pulse&#x02010;wave velocity and pulse&#x02010;wave analysis) recorded using the Vicorder (Skidmore Medical) and SphygmoCor&#x02122; apparatus (AtCor Medical).</p><p>After lying supine at rest for at least 20 minutes, l&#x02010;NMMA was infused intravenously over 5 minutes (total dose 3 mg/kg)<sup><xref ref-type="bibr" rid="b26">26</xref></sup> via a 17&#x02010;gauge intravenous cannula inserted into a large antecubital vein of the dominant arm, and hemodynamic measurements were recorded for the following 45 minutes.</p></sec><sec><title>Biochemical Analyses</title><p>Blood samples were analyzed for total and differential cell counts by an auto analyzer (Sysmex XE2100, Sysmex Europe GmbH). Plasma samples were collected into ethylene diamine tetra&#x02010;acetic acid and kept on ice until centrifuged at 2000<italic>g</italic> for 30 minutes at 4&#x000b0;C. Serum samples were collected and left to clot on melting ice for 60 minutes before being centrifuged at 2000<italic>g</italic> for 10 minutes at 4&#x000b0;C. Samples were immediately frozen and stored at &#x02212;80&#x000b0;C prior to subsequent analysis.</p><p>Plasma was analyzed for the endogenous NOS inhibitors asymmetric dimethylarginine (ADMA) and symmetric dimethylarginine (SDMA) as well as the NO precursors l&#x02010;arginine and l&#x02010;homoarginine using a high&#x02010;performance liquid chromatography (HPLC) method as described previously.<sup><xref ref-type="bibr" rid="b27">27</xref></sup> Briefly, arginine, homoarginine, ADMA, and SDMA were extracted from plasma using Isolute PRS cation exchange solid phase extraction columns (1 mL/50 mg; Kinesis Ltd). The columns were consecutively washed with borate buffer (1 mL), water (3 mL), and methanol (3 mL) before analytes were eluted with 3 mL of a solution containing 50% methanol and 10% concentrated ammonia in water. The eluent was then evaporated to dryness at 80&#x000b0;C under air. The dried extract was then dissolved in 0.1 mL water and 0.1 mL of the derivization reagent (10 mg of <italic>ortho</italic>&#x02010;phthaldialdehyde dissolved in 0.2 mL methanol followed by the addition of 1.8 mL of 200 nmol/L borate buffer and 10 &#x003bc;L of 3&#x02010;mercaptopropionic acid, then diluted 5&#x02010;fold using 200 nmol/L borate buffer immediately before use) before being transferred to autosampler vials, maintained at 10&#x000b0;C, and 20 &#x003bc;L was injected into the HPLC analytical column for chromatography. Following separation, arginine, homoarginine, ADMA, and SDMA were measured fluorimetrically (Waters 2475, Waters) and quantified using single&#x02010;level calibration using an internal standard (80 &#x003bc;L of 5 &#x003bc;mol/L monoethylarginine) added before sample extraction.</p><p>Blood samples obtained for the measurement of plasma nitrite were collected into lithium heparin, immediately transferred to Eppendorf<sup>&#x000ae;</sup> tubes prewashed with Milli&#x02010;Q deionized water, and immediately centrifuged at 5000<italic>g</italic> for 1 minute. Plasma was then transferred into a dark colored Eppendorf<sup>&#x000ae;</sup> tube containing 100 &#x003bc;L of a solution containing 1 mmol/L diethylenetriamine&#x02010;pentaacetic acid and 62.5 mmol/L N&#x02010;ethylmaleimide before being snap&#x02010;frozen on dry ice and stored at &#x02212;80&#x000b0;C prior to further analysis.</p><p>Plasma nitrite samples were defrosted on ice before 100 &#x003bc;L was injected into a reaction vial containing glacial acetic acid and iodide.<sup><xref ref-type="bibr" rid="b28">28</xref></sup> NO generated in the reaction chamber was driven off by a continual stream of oxygen&#x02010;free nitrogen and detected in the exhaust gas using a Sievers NOA 280i chemiluminescent analyzer (Analytix, Co). Analyses were performed in triplicate. The limit of detection of this assay was &#x02248;30 nmol/L with a coefficient of variation of 3.1% for a 250 nmol/L standard.</p></sec><sec><title>Data Analysis and Statistics</title><p>Plethysmography data were analyzed as described previously.<sup><xref ref-type="bibr" rid="b29">29</xref>&#x02013;<xref ref-type="bibr" rid="b30">30</xref></sup> Data are expressed as mean&#x000b1;standard deviation (SD) unless otherwise stated. Statistical analyses were performed using Student's paired <italic>t</italic>&#x02010;tests and 2&#x02010;way analysis of variance (ANOVA) with repeated measures where appropriate. Statistical significance was taken as 2&#x02010;sided <italic>P</italic>&#x0003c;0.05. All analyses were performed using GraphPad Prism (Version 4 for Macintosh, GraphPad Software) on a Macintosh personal computer.</p></sec></sec><sec sec-type="other"><title>Results</title><p>Thirty subjects completed the study protocols (<xref ref-type="table" rid="tbl01">Table 1</xref>) with 5 subjects common to both protocols. All studies were generally well tolerated with no significant adverse events. There were no changes in any indices of lung function (FEV<sub>1</sub>, FVC, and VC) or in hemoglobin concentration, white cell count (or differential cell counts) or platelet count throughout all studies (<italic>P</italic>&#x0003e;0.05 for all; data not shown).</p><table-wrap id="tbl01" position="float"><label>Table 1.</label><caption><p>Baseline Characteristics of Study Participants</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">Baseline Characteristics</th><th align="left" rowspan="1" colspan="1">Study 1: Forearm Study (n=16)</th><th align="left" rowspan="1" colspan="1">Study 2: Systemic l&#x02010;NMMA (n=14)</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Age, y (median, range)</td><td align="left" rowspan="1" colspan="1">23 (21 to 27)</td><td align="left" rowspan="1" colspan="1">26 (23 to 34)</td></tr><tr><td align="left" rowspan="1" colspan="1">Male/Female</td><td align="left" rowspan="1" colspan="1">9 (56%)/7 (44%)</td><td align="left" rowspan="1" colspan="1">8 (57%)/6 (43%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Use of oral contraceptive (female)</td><td align="left" rowspan="1" colspan="1">5 (72%)</td><td align="left" rowspan="1" colspan="1">3 (50%)</td></tr><tr><td align="left" colspan="3" rowspan="1">Height, cm</td></tr><tr><td align="left" rowspan="1" colspan="1">All</td><td align="left" rowspan="1" colspan="1">176&#x000b1;9</td><td align="left" rowspan="1" colspan="1">178&#x000b1;11</td></tr><tr><td align="left" rowspan="1" colspan="1">Male</td><td align="left" rowspan="1" colspan="1">181&#x000b1;7</td><td align="left" rowspan="1" colspan="1">186&#x000b1;6</td></tr><tr><td align="left" rowspan="1" colspan="1">Female</td><td align="left" rowspan="1" colspan="1">169&#x000b1;6</td><td align="left" rowspan="1" colspan="1">167&#x000b1;5</td></tr><tr><td align="left" colspan="3" rowspan="1">Weight, kg</td></tr><tr><td align="left" rowspan="1" colspan="1">All</td><td align="left" rowspan="1" colspan="1">72&#x000b1;13</td><td align="left" rowspan="1" colspan="1">74&#x000b1;14</td></tr><tr><td align="left" rowspan="1" colspan="1">Male</td><td align="left" rowspan="1" colspan="1">80&#x000b1;11</td><td align="left" rowspan="1" colspan="1">85&#x000b1;6</td></tr><tr><td align="left" rowspan="1" colspan="1">Female</td><td align="left" rowspan="1" colspan="1">60&#x000b1;4</td><td align="left" rowspan="1" colspan="1">60&#x000b1;3</td></tr><tr><td align="left" colspan="3" rowspan="1">BMI, kg/m<sup>2</sup></td></tr><tr><td align="left" rowspan="1" colspan="1">All</td><td align="left" rowspan="1" colspan="1">23.1&#x000b1;2.8</td><td align="left" rowspan="1" colspan="1">23.2&#x000b1;2.1</td></tr><tr><td align="left" rowspan="1" colspan="1">Male</td><td align="left" rowspan="1" colspan="1">24.6&#x000b1;2.8</td><td align="left" rowspan="1" colspan="1">24.6&#x000b1;1.4</td></tr><tr><td align="left" rowspan="1" colspan="1">Female</td><td align="left" rowspan="1" colspan="1">21.2&#x000b1;1.0</td><td align="left" rowspan="1" colspan="1">21.5&#x000b1;1.5</td></tr></tbody></table><table-wrap-foot><fn><p>Data expressed as mean&#x000b1;standard deviation unless otherwise stated. l&#x02010;NMMA indicates N<sup>G</sup>&#x02010;monomethyl&#x02010;l&#x02010;arginine; BMI, body mass index.</p></fn></table-wrap-foot></table-wrap><sec><title>Plasma Nitrite and Arginine Concentrations</title><p>Two hours following exposure to diesel exhaust, plasma nitrite concentrations were higher as compared to the filtered air exposure (68&#x000b1;48 versus 41&#x000b1;32 nmol/L; <italic>P</italic>=0.006). In contrast, there were no differences in plasma concentrations of the NO precursor l&#x02010;homoarginine, or in the endogenous NOS inhibitors ADMA and SDMA at 2 or 6 hour following exposures (<xref ref-type="table" rid="tbl02">Table 2</xref>). Plasma concentrations of the NO precursor l&#x02010;arginine were lower after exposure to diesel exhaust as compared to filtered air (<italic>P</italic>=0.043).</p><table-wrap id="tbl02" position="float"><label>Table 2.</label><caption><p>Plasma Concentrations of NOS Substrates and Endogenous NOS Inhibitors</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2" colspan="1">Parameter</th><th align="left" rowspan="2" colspan="1">Exposure</th><th align="left" rowspan="2" colspan="1">Baseline</th><th align="left" rowspan="2" colspan="1">2 Hour</th><th align="left" rowspan="2" colspan="1">6 Hour</th><th align="left" colspan="2" rowspan="1"><italic>P</italic> value</th></tr><tr><th align="left" rowspan="1" colspan="1">Time</th><th align="left" rowspan="1" colspan="1">Exp</th></tr></thead><tbody><tr><td align="left" rowspan="2" colspan="1">l&#x02010;Arginine, &#x003bc;mol/L</td><td align="left" rowspan="1" colspan="1">Air</td><td align="left" rowspan="1" colspan="1">74.1&#x000b1;16.3</td><td align="left" rowspan="1" colspan="1">61.6&#x000b1;17.8</td><td align="left" rowspan="1" colspan="1">59.3&#x000b1;10.6</td><td align="left" rowspan="2" colspan="1">0.006</td><td align="left" rowspan="2" colspan="1">0.006</td></tr><tr><td align="left" rowspan="1" colspan="1">Diesel</td><td align="left" rowspan="1" colspan="1">67.7&#x000b1;13.4</td><td align="left" rowspan="1" colspan="1">58.2&#x000b1;10.0</td><td align="left" rowspan="1" colspan="1">54.6&#x000b1;10.3</td></tr><tr><td align="left" rowspan="2" colspan="1">l&#x02010;Homoarginine, &#x003bc;mol/L</td><td align="left" rowspan="1" colspan="1">Air</td><td align="left" rowspan="1" colspan="1">1.75&#x000b1;0.46</td><td align="left" rowspan="1" colspan="1">1.66&#x000b1;0.48</td><td align="left" rowspan="1" colspan="1">1.70&#x000b1;0.51</td><td align="left" rowspan="2" colspan="1">0.913</td><td align="left" rowspan="2" colspan="1">0.412</td></tr><tr><td align="left" rowspan="1" colspan="1">Diesel</td><td align="left" rowspan="1" colspan="1">1.67&#x000b1;0.51</td><td align="left" rowspan="1" colspan="1">1.63&#x000b1;0.48</td><td align="left" rowspan="1" colspan="1">1.69&#x000b1;0.53</td></tr><tr><td align="left" rowspan="2" colspan="1">ADMA, &#x003bc;mol/L</td><td align="left" rowspan="1" colspan="1">Air</td><td align="left" rowspan="1" colspan="1">0.52&#x000b1;0.08</td><td align="left" rowspan="1" colspan="1">0.44&#x000b1;0.09</td><td align="left" rowspan="1" colspan="1">0.51&#x000b1;0.07</td><td align="left" rowspan="2" colspan="1">0.010</td><td align="left" rowspan="2" colspan="1">0.374</td></tr><tr><td align="left" rowspan="1" colspan="1">Diesel</td><td align="left" rowspan="1" colspan="1">0.51&#x000b1;0.05</td><td align="left" rowspan="1" colspan="1">0.44&#x000b1;0.06</td><td align="left" rowspan="1" colspan="1">0.50&#x000b1;0.07</td></tr><tr><td align="left" rowspan="2" colspan="1">SDMA, &#x003bc;mol/L</td><td align="left" rowspan="1" colspan="1">Air</td><td align="left" rowspan="1" colspan="1">0.43&#x000b1;0.06</td><td align="left" rowspan="1" colspan="1">0.41&#x000b1;0.07</td><td align="left" rowspan="1" colspan="1">0.43&#x000b1;0.05</td><td align="left" rowspan="2" colspan="1">0.451</td><td align="left" rowspan="2" colspan="1">0.449</td></tr><tr><td align="left" rowspan="1" colspan="1">Diesel</td><td align="left" rowspan="1" colspan="1">0.41&#x000b1;0.05</td><td align="left" rowspan="1" colspan="1">0.41&#x000b1;0.05</td><td align="left" rowspan="1" colspan="1">0.43&#x000b1;0.05</td></tr></tbody></table><table-wrap-foot><fn><p>Plasma concentrations of endogenous NOS inhibitors and NOS substrates at baseline, 2 and 6 hours after the exposure during Study 1 (local l&#x02010;NMMA administration). All data expressed as mean&#x000b1;standard deviation. <italic>P</italic>&#x02010;values from 2&#x02010;way repeated measures ANOVA. NOS indicates nitric oxide synthase; ADMA, asymmetric dimethylarginine; SDMA, symmetric dimethylarginine.</p></fn></table-wrap-foot></table-wrap></sec><sec><title>Study 1: Local Nitric Oxide Synthase Inhibition</title><p>Sixteen subjects, median age 23 years (<xref ref-type="table" rid="tbl01">Table 1</xref>), completed the study protocol: one subject failed to attend scheduled visits and one was withdrawn for technical reasons (failed cannulation). Blood pressure, heart rate, and baseline forearm blood flow were not different following either exposure (<italic>P</italic>&#x0003e;0.05 for all; data not shown).</p><p>Infusion of the NOS inhibitor, l&#x02010;NMMA, resulted in a similar dose&#x02010;dependent vasoconstriction following both exposures (<italic>P</italic>=0.559; <xref ref-type="fig" rid="fig01">Figure 1</xref>A). After establishing the NO clamp by restoring basal blood flow with SNP coinfusion (208&#x000b1;33 and 236&#x000b1;26 ng/min following air and diesel exhaust exposure respectively; <italic>P</italic>=0.453), both acetylcholine and SNP caused dose&#x02010;dependent vasodilatation (<italic>P</italic>&#x0003c;0.01 for both) that was attenuated in comparison to previous studies.<sup><xref ref-type="bibr" rid="b6">6</xref></sup> However, this vasodilatation was similar following both exposures (dilute diesel exhaust versus filter air: <italic>P</italic>=0.209 for acetylcholine and <italic>P</italic>=0.613 for sodium nitroprusside; <xref ref-type="fig" rid="fig01">Figure 1</xref>B).</p><fig id="fig01" position="float"><label>Figure 1.</label><caption><p>A, Forearm blood flow response during infusion of l&#x02010;NMMA (2&#x02010;way repeated measures ANOVA:<italic> P</italic>=0.559 for exposure). B, Forearm blood flow during infusion of the vasodilators acetylcholine and sodium nitroprusside (2&#x02010;way repeated measures ANOVA:<italic> P</italic>=0.209 and <italic>P</italic>=0.613, respectively, for exposure). Data expressed as mean&#x000b1;SEM. l&#x02010;NMMA indicates N<sup>G</sup>&#x02010;monomethyl&#x02010;l&#x02010;arginine; ANOVA, analysis of variance; SEM, standard error of the mean.</p></caption><graphic xlink:href="jah3-2-e004309-g1"/></fig></sec><sec><title>Study 2: Systemic Nitric Oxide Synthase Inhibition</title><p>Fourteen subjects, median age 26 years (<xref ref-type="table" rid="tbl01">Table 1</xref>), completed the study protocol: one subject was withdrawn for technical reasons (failed cannulation). There were no differences in hemodynamic or biochemical indices at baseline prior to either exposure (<xref ref-type="table" rid="tbl03">Table 3</xref>).</p><table-wrap id="tbl03" position="float"><label>Table 3.</label><caption><p>Baseline Hemodynamic and Biochemical Parameters Prior to Exposure for the Systemic Administration of l&#x02010;NMMA Study</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">Parameter</th><th align="left" rowspan="1" colspan="1">Air</th><th align="left" rowspan="1" colspan="1">Diesel</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Heart rate, bpm</td><td align="left" rowspan="1" colspan="1">67&#x000b1;13</td><td align="left" rowspan="1" colspan="1">65&#x000b1;8</td></tr><tr><td align="left" rowspan="1" colspan="1">Systolic blood pressure, mm Hg</td><td align="left" rowspan="1" colspan="1">124&#x000b1;12</td><td align="left" rowspan="1" colspan="1">124&#x000b1;16</td></tr><tr><td align="left" rowspan="1" colspan="1">Diastolic blood pressure, mm Hg</td><td align="left" rowspan="1" colspan="1">70&#x000b1;6</td><td align="left" rowspan="1" colspan="1">70&#x000b1;6</td></tr><tr><td align="left" rowspan="1" colspan="1">Mean arterial pressure, mm Hg</td><td align="left" rowspan="1" colspan="1">88&#x000b1;6</td><td align="left" rowspan="1" colspan="1">88&#x000b1;8</td></tr><tr><td align="left" rowspan="1" colspan="1">Pulse wave velocity, m/s</td><td align="left" rowspan="1" colspan="1">5.8&#x000b1;0.6</td><td align="left" rowspan="1" colspan="1">5.8&#x000b1;0.5</td></tr><tr><td align="left" rowspan="1" colspan="1">Augmentation index (AIx), %</td><td align="left" rowspan="1" colspan="1">&#x02212;3&#x000b1;9</td><td align="left" rowspan="1" colspan="1">1&#x000b1;10</td></tr><tr><td align="left" rowspan="1" colspan="1">AIx75, %</td><td align="left" rowspan="1" colspan="1">&#x02212;8&#x000b1;9</td><td align="left" rowspan="1" colspan="1">&#x02212;6&#x000b1;11</td></tr><tr><td align="left" rowspan="1" colspan="1">Augmentation pressure, mm Hg</td><td align="left" rowspan="1" colspan="1">&#x02212;1&#x000b1;4</td><td align="left" rowspan="1" colspan="1">0&#x000b1;4</td></tr><tr><td align="left" rowspan="1" colspan="1">Time to wave reflection, ms</td><td align="left" rowspan="1" colspan="1">164&#x000b1;20</td><td align="left" rowspan="1" colspan="1">172&#x000b1;38</td></tr><tr><td align="left" rowspan="1" colspan="1">Cardiac index, L/min per m<sup>2</sup></td><td align="left" rowspan="1" colspan="1">4.8&#x000b1;0.8</td><td align="left" rowspan="1" colspan="1">5.0&#x000b1;0.8</td></tr><tr><td align="left" rowspan="1" colspan="1">Stroke index, mL/beat per m<sup>2</sup></td><td align="left" rowspan="1" colspan="1">76&#x000b1;12</td><td align="left" rowspan="1" colspan="1">81&#x000b1;17</td></tr><tr><td align="left" rowspan="1" colspan="1">PVRI, dynes.min/cm<sup>5</sup> per m<sup>2</sup></td><td align="left" rowspan="1" colspan="1">91&#x000b1;20</td><td align="left" rowspan="1" colspan="1">88&#x000b1;26</td></tr><tr><td align="left" rowspan="1" colspan="1">Hemoglobin, g/dL</td><td align="left" rowspan="1" colspan="1">144&#x000b1;14</td><td align="left" rowspan="1" colspan="1">140&#x000b1;12</td></tr><tr><td align="left" rowspan="1" colspan="1">Hematocrit, %</td><td align="left" rowspan="1" colspan="1">41&#x000b1;2</td><td align="left" rowspan="1" colspan="1">41&#x000b1;3</td></tr><tr><td align="left" rowspan="1" colspan="1">White cell count, &#x000d7;10<sup>9</sup>/L</td><td align="left" rowspan="1" colspan="1">5.9&#x000b1;0.9</td><td align="left" rowspan="1" colspan="1">5.5&#x000b1;0.8</td></tr><tr><td align="left" rowspan="1" colspan="1">Neutrophil count, &#x000d7;10<sup>9</sup>/L</td><td align="left" rowspan="1" colspan="1">3.1&#x000b1;0.8</td><td align="left" rowspan="1" colspan="1">2.7&#x000b1;0.7</td></tr><tr><td align="left" rowspan="1" colspan="1">Monocyte count, &#x000d7;10<sup>9</sup>/L</td><td align="left" rowspan="1" colspan="1">0.5&#x000b1;0.2</td><td align="left" rowspan="1" colspan="1">0.5&#x000b1;0.1</td></tr><tr><td align="left" rowspan="1" colspan="1">Lymphocyte count, &#x000d7;10<sup>9</sup>/L</td><td align="left" rowspan="1" colspan="1">2.0&#x000b1;0.3</td><td align="left" rowspan="1" colspan="1">2.1&#x000b1;0.4</td></tr><tr><td align="left" rowspan="1" colspan="1">Platelet count, &#x000d7;10<sup>9</sup>/L</td><td align="left" rowspan="1" colspan="1">224&#x000b1;38</td><td align="left" rowspan="1" colspan="1">226&#x000b1;33</td></tr><tr><td align="left" rowspan="1" colspan="1">Blood urea nitrogen, mg/dL</td><td align="left" rowspan="1" colspan="1">16.8&#x000b1;7.6</td><td align="left" rowspan="1" colspan="1">16.8&#x000b1;7.6</td></tr><tr><td align="left" rowspan="1" colspan="1">Creatinine, mg/dL</td><td align="left" rowspan="1" colspan="1">0.85&#x000b1;0.16</td><td align="left" rowspan="1" colspan="1">0.85&#x000b1;0.16</td></tr><tr><td align="left" rowspan="1" colspan="1">Sodium, mmol/L</td><td align="left" rowspan="1" colspan="1">141&#x000b1;1</td><td align="left" rowspan="1" colspan="1">141&#x000b1;1</td></tr><tr><td align="left" rowspan="1" colspan="1">Potassium, mmol/L</td><td align="left" rowspan="1" colspan="1">4.3&#x000b1;0.3</td><td align="left" rowspan="1" colspan="1">4.2&#x000b1;0.3</td></tr><tr><td align="left" rowspan="1" colspan="1">TCO<sub>2</sub>, mmol/L</td><td align="left" rowspan="1" colspan="1">28&#x000b1;3</td><td align="left" rowspan="1" colspan="1">28&#x000b1;2</td></tr><tr><td align="left" rowspan="1" colspan="1">eGFR, mL/min per 1.73 m<sup>2</sup></td><td align="left" rowspan="1" colspan="1">121&#x000b1;26</td><td align="left" rowspan="1" colspan="1">122&#x000b1;26</td></tr></tbody></table><table-wrap-foot><fn><p>Data expressed as mean&#x000b1;standard deviation. l&#x02010;NMMA indicates N<sup>G</sup>&#x02010;monomethyl&#x02010;l&#x02010;arginine; bpm, beats per minute; AIx, augmentation index corrected for a heart rate of 75 bpm; PVRI, peripheral vascular resistance index; TCO<sub>2</sub>, total carbon dioxide; eGFR, estimated glomerular filtration rate.</p></fn></table-wrap-foot></table-wrap><p>Following exposure to diesel exhaust, l&#x02010;NMMA caused a greater increase in blood pressure (<italic>P</italic>=0.048) and central arterial stiffness (<italic>P</italic>=0.007) with similar reductions in cardiac output and increases in systemic vascular resistance (<italic>P</italic>&#x0003e;0.05 for both) as compared to filtered air (<xref ref-type="fig" rid="fig02">Figure 2</xref>).</p><fig id="fig02" position="float"><label>Figure 2.</label><caption><p>Changes in invasive mean arterial blood pressure, central arterial stiffness (PWV), cardiac index, and stroke volume following systemic infusion of l&#x02010;NMMA. Data expressed as mean&#x000b1;SEM and composite area under the curve with 2&#x02010;way repeated measures ANOVA for exposure. PWV indicates pulse&#x02010;wave velocity; l&#x02010;NMMA, N<sup>G</sup>&#x02010;monomethyl&#x02010;l&#x02010;arginine; SEM, standard error of the mean; ANOVA, analysis of variance.</p></caption><graphic xlink:href="jah3-2-e004309-g2"/></fig></sec></sec><sec sec-type="other"><title>Discussion</title><p>We have demonstrated that inhalation of dilute diesel exhaust increases plasma nitrite concentrations suggesting an increase in basal NO release. However, local NO synthase inhibition causes similar degrees of vasoconstriction following both diesel exhaust and filtered air exposure. This suggests a balanced increase in basal NO generation and consumption that attempts to maintain basal peripheral resistance vessel tone. This is consistent with our observation that diesel exhaust inhalation&#x02010;induced vasomotor dysfunction<sup><xref ref-type="bibr" rid="b31">31</xref></sup> is no longer demonstrable in the presence of the NO clamp. In contrast to the peripheral resistance vessel responses, systemic NO synthase inhibition demonstrated an increase in systemic arterial stiffness and blood pressure suggesting that, in conduit vessels, reduced NO bioavailability has more marked effects that cannot be adequately compensated for by increased basal NO release.</p><p>We demonstrated higher basal venous plasma nitrite concentrations following diesel exhaust exposure. These data are consistent with the upregulation of vascular NO generation, which we suggest may represent a homeostatic feedback loop to compensate for increased consumption by local oxidative stress in order to maintain basal vascular tone and blood pressure. While it is unlikely that changes in NO generation reflect upregulation of gene expression, there is growing evidence that endothelial NOS (eNOS) can be rapidly upregulated or induced by enzyme phosphorylation and alterations in protein&#x02013;protein interactions<sup><xref ref-type="bibr" rid="b32">32</xref></sup> and we suggest that these interactions are responsible for the increased NO generation due to local inflammation and oxidative stress. Indeed, these interactions occur very rapidly in animal models, with LPS&#x02010;induced inflammation increasing eNOS activity almost 2&#x02010;fold within 1 hour.<sup><xref ref-type="bibr" rid="b33">33</xref></sup> We believe this effect is likely to be driven by changes in eNOS activity although the exact isoform of the NOS enzyme responsible is unclear from our study given the nonselective inhibition by l&#x02010;NMMA. Previous studies in murine models have demonstrated an increase in inducible&#x02010;NOS (iNOS) expression following exposure to dilute diesel exhaust,<sup><xref ref-type="bibr" rid="b34">34</xref>&#x02013;<xref ref-type="bibr" rid="b35">35</xref></sup> and certainly iNOS has the capacity to be rapidly upregulated in response to insult. The possibility of an effect on iNOS expression remains unexplored at this time.</p><p>We have previously demonstrated in isolated rat aortic rings that diesel exhaust particles attenuate endothelium&#x02010;derived vasorelaxation. This effect was reversed by coincubation with superoxide dismutase thereby reducing oxygen&#x02010;centered free radical production.<sup><xref ref-type="bibr" rid="b36">36</xref></sup> We have also shown that diesel exhaust particles themselves reduce the concentrations of bioavailable NO from the NO donor DEA/NO (2&#x02010;(N,N&#x02010;diethylamino)&#x02010;diazenolate&#x02010;2&#x02010;oxide).<sup><xref ref-type="bibr" rid="b19">19</xref></sup> Nurkiewicz and colleagues have reported that, following inhalation of titanium dioxide nanoparticles, local NO was scavenged by oxygen&#x02010;centered free radicals.<sup><xref ref-type="bibr" rid="b20">20</xref></sup> This reduction in NO bioavailability appears to be driven either by the uncoupling of endothelial NOS by diesel exhaust particles or by local oxidative stress.<sup><xref ref-type="bibr" rid="b37">37</xref></sup> However, while reflective of production and consumption of NO across the vascular bed, plasma nitrite concentrations do not definitively describe the activity of the NOS enzymes and their isoforms. It remains feasible that some of the increase in plasma nitrite is in fact due to absorption from the higher oxides of nitrogen during the exposure itself. Knuckles and colleagues have recently reported that following diesel exhaust exposure, rats had increased plasma NO<sub>x</sub> (nitrate and nitrite combined) concentrations that appeared to be predominantly the result of absorption of NO from the exposure itself, although they exhibited significant increases in eNOS expression consistent with increased NO production.<sup><xref ref-type="bibr" rid="b38">38</xref></sup> Controlled exposures to NO and nitrogen dioxide in humans with subsequent measurements of plasma nitrite concentrations may help to define this further.</p><p>The concept of local oxidative stress is thought to underlie vascular endothelial dysfunction in clinical states such as hypertension, diabetes mellitus, and hypercholesterolemia,<sup><xref ref-type="bibr" rid="b39">39</xref></sup> and has been proposed as the central mechanism linking the cardiovascular, respiratory, and inflammatory responses to inhaled particulate air pollution.<sup><xref ref-type="bibr" rid="b40">40</xref></sup> Measurement of oxidative stress is, however, extremely difficult to quantify due to the short half&#x02010;life and high reactivity of free radicals, and because we are largely left to measure surrogate markers such as isoprostanes and oxidative DNA adducts to determine increases in free radical production in clinical models. As such, the clinical evidence for increased oxidative stress following exposure to air pollutants is limited, and existing studies are inconsistent, although a recently published meta&#x02010;analysis suggests that there is a robust relationship between exposure to particulate air pollution and increases in oxidative DNA adducts and oxidized lipids in man.<sup><xref ref-type="bibr" rid="b41">41</xref></sup> While outside of the scope of this study, we have previously measured plasma nitrotyrosines and urinary isoprostanes following exposure to dilute diesel exhaust, and these results are presented in an online supplement (Data S1).</p><p>Although the plasma concentration of the NO precursor l&#x02010;arginine was generally lower after exposure to diesel exhaust, plasma concentrations of l&#x02010;homoarginine were unaffected and there were no changes in concentration over time. These precursors, l&#x02010;arginine and l&#x02010;homoarginine, are present in vast molar excess as only 1.2% of plasma arginine used for whole&#x02010;body NO production.<sup><xref ref-type="bibr" rid="b42">42</xref>&#x02013;<xref ref-type="bibr" rid="b43">43</xref></sup> The small differences in plasma concentration, which are most likely attributable to dietary intake, are of little functional significance and cannot account for differences in NO production or availability. Similarly, given the small amount of l&#x02010;arginine/l&#x02010;homoarginine required to produce NO, we suggest short&#x02010;term modest increases in NO generation are unlikely to affect their plasma concentrations or indeed those of the naturally occurring endogenous NOS inhibitors, such as ADMA.</p><p>Individuals with hypercholesterolemia have impaired vascular vasomotor dysfunction: the classic paradigm of vascular endothelial dysfunction as a result of changes in the l&#x02010;arginine&#x02010;NO pathway.<sup><xref ref-type="bibr" rid="b44">44</xref>&#x02013;<xref ref-type="bibr" rid="b45">45</xref></sup> However, these subjects have normal responses to NOS inhibition with l&#x02010;NMMA, but reduced vasodilatation to endothelium&#x02010;dependent vasodilators such as acetylcholine and serotonin.<sup><xref ref-type="bibr" rid="b46">46</xref></sup> In the present studies, we demonstrate the same pattern of vascular dysfunction following the inhalation of dilute diesel exhaust. Indeed, in the presence of the NO clamp, and the absence of endogenous NO release, the previously demonstrated attenuation in vascular vasomotor responses following diesel exhaust inhalation<sup><xref ref-type="bibr" rid="b31">31</xref></sup> is abolished. These findings are consistent with the suggestion that basal NO generation is already increased so further stimulation may be proportionately less effective, and that the NO released may be consumed more rapidly by local oxidative stress. Furthermore, given that the responses to stimulation with acetylcholine are similar in the absence of endogenous NO release, this would suggest that the other key vasodilator mechanisms, such as endothelium&#x02010;derived hyperpolarising factor (EDHF) or prostaglandins, are intact and unaffected by diesel exhaust inhalation.</p><p>Administration of the exogenous NOS inhibitor, l&#x02010;NMMA, had the anticipated response of causing peripheral vasoconstriction and a systemic pressor response with reduced cardiac output.<sup><xref ref-type="bibr" rid="b26">26</xref>,<xref ref-type="bibr" rid="b47">47</xref>&#x02013;<xref ref-type="bibr" rid="b51">51</xref></sup> The control of basal vascular tone and vascular reactivity is complex and is known to vary in the different vascular beds. The regulation of conduit arterial tone is almost solely dependent on endothelial NO production, and alternative vasodilator mechanisms, such as EDHF, appear to play little role.<sup><xref ref-type="bibr" rid="b52">52</xref></sup> In contrast, the vasomotor responses in resistance vessels are mediated through NO, EDHF, and prostaglandin pathways.<sup><xref ref-type="bibr" rid="b53">53</xref>&#x02013;<xref ref-type="bibr" rid="b54">54</xref></sup> Indeed, endogenous NO release reflects only lower levels of vasodilatation, with EDHF compensating and providing a greater contribution to the vasomotor response especially with higher degrees of vasodilatation. We therefore suggest that in the conduit vessels, the increase in endogenous NO production following diesel exhaust inhalation can offset the increased consumption of NO in the context of increased local oxidative stress, thus suppressing a potential pressor effect. However, in the presence of systemic NOS inhibition, this potential pressor effect is unmasked and we see an increase in blood pressure and arterial stiffness. This enhanced sensitivity of the central arterial tree may underlie the increases in blood pressure seen with acute<sup><xref ref-type="bibr" rid="b8">8</xref>,<xref ref-type="bibr" rid="b55">55</xref></sup> and chronic<sup><xref ref-type="bibr" rid="b56">56</xref></sup> exposures to particulate air pollutants. Alternatively, the increase in NO concentrations following exposure to diesel exhaust may reflect increased bioavailability of NO within the vasculature, and an enhanced pressor response to systemic l&#x02010;NMMA infusion. However, this would not be consistent with the similar basal blood flow and vasomotor response to l&#x02010;NMMA in the forearm circulation.</p><p>While we suggest that changes in NO bioavailability are consistent with our findings, a similar effect may be seen with other mechanisms, such as activation of the autonomic nervous system. Such activation will also cause an increase in vascular tone as well as a pressor and arterial stiffness response. Indeed, changes in autonomic nervous system activation may underlie the acute vasoconstriction<sup><xref ref-type="bibr" rid="b7">7</xref></sup> and changes in heart rate variability previously reported.<sup><xref ref-type="bibr" rid="b57">57</xref></sup> Further studies are warranted to evaluate the contribution of the autonomic nervous system to these important vascular effects.</p><sec><title>Limitations</title><p>This study was undertaken in order to examine changes in blood pressure and arterial vasomotor function as measured by venous occlusion plethysmography. While the robust crossover design increases the statistical power of the study, we recognize that for some secondary outcomes this study may have been unable to definitively identify a lack of effect.</p></sec></sec><sec sec-type="other"><title>Conclusions</title><p>In these studies we have demonstrated for the first time in humans that inhalation of dilute diesel exhaust results in higher basal plasma nitrite concentrations. This is consistent with homeostatic regulation in the presence of increased NO consumption due to local oxidative stress. Similarly, we have shown that in the presence of the NO clamp and the absence of endogenous NO production, diesel exhaust inhalation does not result in further vascular impairment. Furthermore, diesel exhaust inhalation exaggerates the pressor and vasoconstrictor effects of systemic NO synthase inhibition consistent with the proposed changes in NO production and consumption. We conclude that the vascular dysfunction associated with diesel exhaust inhalation is mediated predominantly by reduced NO bioavailability.</p></sec></body><back><fn-group><title>Sources of Funding</title><fn fn-type="financial-disclosure"><p>This research was supported by a British Heart Foundation Programme Grant (RG/10/9/28286), the Swedish Heart Lung Foundation, and the V&#x000e4;sterbotten County Council, Sweden. Dr Langrish and Dr Mills are supported by the British Heart Foundation through a Clinical PhD Studentship (FS/07/048) and Intermediate Clinical Research Fellowship (FS/10/024/28266) respectively, and Dr Blomberg was the holder of the Lars Werk&#x000f6; Distinguished Research Fellowship from the Swedish Heart Lung Foundation.</p></fn></fn-group><fn-group><title>Disclosures</title><fn fn-type="financial-disclosure"><p>None.</p></fn></fn-group><sec><title>Acknowledgments</title><p>We thank Annika Johansson, Frida Holmstr&#x000f6;m, Ann&#x02010;Britt Lundstr&#x000f6;m, Ester Roos&#x02010;Engstrand, Maj&#x02010;Cari Ledin, and the Department of Respiratory Medicine and Allergy (University Hospital, Ume&#x000e5;). We also thank the staff at Svensk Maskinprovning AB (Ume&#x000e5;), the Department of Clinical Biochemistry (Royal Infirmary, Glasgow).</p></sec><ref-list><title>References</title><ref id="b1"><label>1</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anderson</surname><given-names>HR</given-names></name><name><surname>Ponce de Leon</surname><given-names>A</given-names></name><name><surname>Bland</surname><given-names>JM</given-names></name><name><surname>Bower</surname><given-names>JS</given-names></name><name><surname>Strachan</surname><given-names>DP</given-names></name></person-group>
<article-title>Air pollution and daily mortality in London: 1987&#x02013;92</article-title>. <source>BMJ</source>. <year>1996</year>;
<volume>312</volume>:<fpage>665</fpage>-<lpage>669</lpage><pub-id pub-id-type="pmid">8597732</pub-id></mixed-citation></ref><ref id="b2"><label>2</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dockery</surname><given-names>D</given-names></name><name><surname>Pope</surname><given-names>C</given-names></name><name><surname>Xu</surname><given-names>X</given-names></name><name><surname>Spengler</surname><given-names>J</given-names></name><name><surname>Ware</surname><given-names>J</given-names></name><name><surname>Fay</surname><given-names>M</given-names></name><name><surname>Ferris</surname><given-names>B</given-names></name><name><surname>Speizer</surname><given-names>F</given-names></name></person-group>
<article-title>An association between air pollution and mortality in six U.S. cities</article-title>. <source>N Engl J Med</source>. <year>1993</year>;
<volume>329</volume>:<fpage>1753</fpage>-<lpage>1759</lpage><pub-id pub-id-type="pmid">8179653</pub-id></mixed-citation></ref><ref id="b3"><label>3</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miller</surname><given-names>K</given-names></name><name><surname>Siscovick</surname><given-names>D</given-names></name><name><surname>Sheppard</surname><given-names>L</given-names></name><name><surname>Shepherd</surname><given-names>K</given-names></name><name><surname>Sullivan</surname><given-names>J</given-names></name><name><surname>Anderson</surname><given-names>G</given-names></name><name><surname>Kaufman</surname><given-names>J</given-names></name></person-group>
<article-title>Long&#x02010;term exposure to air pollution and incidence of cardiovascular events in women</article-title>. <source>N Engl J Med</source>. <year>2007</year>;
<volume>356</volume>:<fpage>447</fpage>-<lpage>458</lpage><pub-id pub-id-type="pmid">17267905</pub-id></mixed-citation></ref><ref id="b4"><label>4</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pope</surname><given-names>C</given-names></name><name><surname>Burnett</surname><given-names>R</given-names></name><name><surname>Thun</surname><given-names>M</given-names></name><name><surname>Calle</surname><given-names>E</given-names></name><name><surname>Krewski</surname><given-names>D</given-names></name><name><surname>Ito</surname><given-names>K</given-names></name><name><surname>Thurston</surname><given-names>G</given-names></name></person-group>
<article-title>Lung cancer, cardiopulmonary mortality, and long&#x02010;term exposure to fine particulate air pollution</article-title>. <source>JAMA</source>. <year>2002</year>;
<volume>287</volume>:<fpage>1132</fpage>-<lpage>1141</lpage><pub-id pub-id-type="pmid">11879110</pub-id></mixed-citation></ref><ref id="b5"><label>5</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peters</surname><given-names>A</given-names></name><name><surname>von Klot</surname><given-names>S</given-names></name><name><surname>Heier</surname><given-names>M</given-names></name><name><surname>Trentinaglia</surname><given-names>I</given-names></name><name><surname>H&#x000f6;rmann</surname><given-names>A</given-names></name><name><surname>Wichmann</surname><given-names>H</given-names></name><name><surname>L&#x000f6;wel</surname><given-names>H</given-names></name></person-group>
<article-title>Exposure to traffic and the onset of myocardial infarction</article-title>. <source>N Engl J Med</source>. <year>2004</year>;
<volume>351</volume>:<fpage>1721</fpage>-<lpage>1730</lpage><pub-id pub-id-type="pmid">15496621</pub-id></mixed-citation></ref><ref id="b6"><label>6</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mills</surname><given-names>N</given-names></name><name><surname>T&#x000f6;rnqvist</surname><given-names>H</given-names></name><name><surname>Robinson</surname><given-names>S</given-names></name><name><surname>Gonzales</surname><given-names>M</given-names></name><name><surname>Darnley</surname><given-names>K</given-names></name><name><surname>MacNee</surname><given-names>W</given-names></name><name><surname>Boon</surname><given-names>N</given-names></name><name><surname>Donaldson</surname><given-names>K</given-names></name><name><surname>Blomberg</surname><given-names>A</given-names></name><name><surname>Sandstr&#x000f6;m</surname><given-names>T</given-names></name><name><surname>Newby</surname><given-names>D</given-names></name></person-group>
<article-title>Diesel exhaust inhalation causes vascular dysfunction and impaired endogenous fibrinolysis</article-title>. <source>Circulation</source>. <year>2005</year>;
<volume>112</volume>:<fpage>3930</fpage>-<lpage>3936</lpage><pub-id pub-id-type="pmid">16365212</pub-id></mixed-citation></ref><ref id="b7"><label>7</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brook</surname><given-names>R</given-names></name><name><surname>Brook</surname><given-names>J</given-names></name><name><surname>Urch</surname><given-names>B</given-names></name><name><surname>Vincent</surname><given-names>R</given-names></name><name><surname>Rajagopalan</surname><given-names>S</given-names></name><name><surname>Silverman</surname><given-names>F</given-names></name></person-group>
<article-title>Inhalation of fine particulate air pollution and ozone causes acute arterial vasoconstriction in healthy adults</article-title>. <source>Circulation</source>. <year>2002</year>;
<volume>105</volume>:<fpage>1534</fpage>-<lpage>1536</lpage><pub-id pub-id-type="pmid">11927516</pub-id></mixed-citation></ref><ref id="b8"><label>8</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Urch</surname><given-names>B</given-names></name><name><surname>Silverman</surname><given-names>F</given-names></name><name><surname>Corey</surname><given-names>P</given-names></name><name><surname>Brook</surname><given-names>JR</given-names></name><name><surname>Lukic</surname><given-names>KZ</given-names></name><name><surname>Rajagopalan</surname><given-names>S</given-names></name><name><surname>Brook</surname><given-names>RD</given-names></name></person-group>
<article-title>Acute blood pressure responses in healthy adults during controlled air pollution exposures</article-title>. <source>Environ Health Perspect</source>. <year>2005</year>;
<volume>113</volume>:<fpage>1052</fpage>-<lpage>1055</lpage><pub-id pub-id-type="pmid">16079078</pub-id></mixed-citation></ref><ref id="b9"><label>9</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heitzer</surname><given-names>T</given-names></name><name><surname>Schlinzig</surname><given-names>T</given-names></name><name><surname>Krohn</surname><given-names>K</given-names></name><name><surname>Meinertz</surname><given-names>T</given-names></name><name><surname>M&#x000fc;nzel</surname><given-names>T</given-names></name></person-group>
<article-title>Endothelial dysfunction, and risk of cardiovascular events in patients with coronary heart disease</article-title>. <source>Circulation</source>. <year>2001</year>;
<volume>104</volume>:<fpage>2673</fpage>-<lpage>2678</lpage><pub-id pub-id-type="pmid">11723017</pub-id></mixed-citation></ref><ref id="b10"><label>10</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nightingale</surname><given-names>J</given-names></name><name><surname>Maggs</surname><given-names>R</given-names></name><name><surname>Cullinan</surname><given-names>P</given-names></name><name><surname>Donnelly</surname><given-names>L</given-names></name><name><surname>Rogers</surname><given-names>D</given-names></name><name><surname>Kinnersley</surname><given-names>R</given-names></name><name><surname>Chung</surname><given-names>KF</given-names></name><name><surname>Barnes</surname><given-names>P</given-names></name><name><surname>Ashmore</surname><given-names>M</given-names></name><name><surname>Newman&#x02010;Taylor</surname><given-names>A</given-names></name></person-group>
<article-title>Airway inflammation after controlled exposure to diesel exhaust particulates</article-title>. <source>Am J Respir Crit Care Med</source>. <year>2000</year>;
<volume>162</volume>:<fpage>161</fpage>-<lpage>166</lpage><pub-id pub-id-type="pmid">10903236</pub-id></mixed-citation></ref><ref id="b11"><label>11</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salvi</surname><given-names>S</given-names></name><name><surname>Blomberg</surname><given-names>A</given-names></name><name><surname>Rudell</surname><given-names>B</given-names></name><name><surname>Kelly</surname><given-names>F</given-names></name><name><surname>Sandstr&#x000f6;m</surname><given-names>T</given-names></name><name><surname>Holgate</surname><given-names>S</given-names></name><name><surname>Frew</surname><given-names>A</given-names></name></person-group>
<article-title>Acute inflammatory responses in the airways and peripheral blood after short&#x02010;term exposure to diesel exhaust in healthy human volunteers</article-title>. <source>Am J Respir Crit Care Med</source>. <year>1999</year>;
<volume>159</volume>:<fpage>702</fpage>-<lpage>709</lpage><pub-id pub-id-type="pmid">10051240</pub-id></mixed-citation></ref><ref id="b12"><label>12</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baulig</surname><given-names>A</given-names></name><name><surname>Garlatti</surname><given-names>M</given-names></name><name><surname>Bonvallot</surname><given-names>V</given-names></name><name><surname>Marchand</surname><given-names>A</given-names></name><name><surname>Barouki</surname><given-names>R</given-names></name><name><surname>Marano</surname><given-names>F</given-names></name><name><surname>Baeza&#x02010;Squiban</surname><given-names>A</given-names></name></person-group>
<article-title>Involvement of reactive oxygen species in the metabolic pathways triggered by diesel exhaust particles in human airway epithelial cells</article-title>. <source>Am J Physiol Lung Cell Moll Physiol</source>. <year>2003</year>;
<volume>285</volume>:<fpage>L671</fpage>-<lpage>L679</lpage></mixed-citation></ref><ref id="b13"><label>13</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Behndig</surname><given-names>A</given-names></name><name><surname>Mudway</surname><given-names>I</given-names></name><name><surname>Brown</surname><given-names>J</given-names></name><name><surname>Stenfors</surname><given-names>N</given-names></name><name><surname>Helleday</surname><given-names>R</given-names></name><name><surname>Duggan</surname><given-names>S</given-names></name><name><surname>Wilson</surname><given-names>S</given-names></name><name><surname>Boman</surname><given-names>C</given-names></name><name><surname>Cassee</surname><given-names>F</given-names></name><name><surname>Frew</surname><given-names>A</given-names></name><name><surname>Kelly</surname><given-names>F</given-names></name><name><surname>Sandstr&#x000f6;m</surname><given-names>T</given-names></name><name><surname>Blomberg</surname><given-names>A</given-names></name></person-group>
<article-title>Airway antioxidant and inflammatory responses to diesel exhaust exposure in healthy humans</article-title>. <source>Eur Respir J</source>. <year>2006</year>;
<volume>27</volume>:<fpage>359</fpage>-<lpage>365</lpage><pub-id pub-id-type="pmid">16452593</pub-id></mixed-citation></ref><ref id="b14"><label>14</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nemmar</surname><given-names>A</given-names></name><name><surname>Hoet</surname><given-names>PH</given-names></name><name><surname>Vanquickenborne</surname><given-names>B</given-names></name><name><surname>Dinsdale</surname><given-names>D</given-names></name><name><surname>Thomeer</surname><given-names>M</given-names></name><name><surname>Hoylaerts</surname><given-names>MF</given-names></name><name><surname>Vanbilloen</surname><given-names>H</given-names></name><name><surname>Mortelmans</surname><given-names>L</given-names></name><name><surname>Nemery</surname><given-names>B</given-names></name></person-group>
<article-title>Passage of inhaled particles into the blood circulation in humans</article-title>. <source>Circulation</source>. <year>2002</year>;
<volume>105</volume>:<fpage>411</fpage>-<lpage>414</lpage><pub-id pub-id-type="pmid">11815420</pub-id></mixed-citation></ref><ref id="b15"><label>15</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nemmar</surname><given-names>A</given-names></name><name><surname>Hoylaerts</surname><given-names>M</given-names></name><name><surname>Hoet</surname><given-names>P</given-names></name><name><surname>Nemery</surname><given-names>B</given-names></name></person-group>
<article-title>Possible mechanisms of the cardiovascular effects of inhaled particles: systemic translocation and prothrombotic effects</article-title>. <source>Toxicol Lett</source>. <year>2004</year>;
<volume>149</volume>:<fpage>243</fpage>-<lpage>253</lpage><pub-id pub-id-type="pmid">15093270</pub-id></mixed-citation></ref><ref id="b16"><label>16</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lum</surname><given-names>H</given-names></name><name><surname>Roebuck</surname><given-names>K</given-names></name></person-group>
<article-title>Oxidant stress and endothelial dysfunction</article-title>. <source>Am J Physiol Cell Physiol</source>. <year>2001</year>;
<volume>280</volume>:<fpage>719</fpage>-<lpage>741</lpage></mixed-citation></ref><ref id="b17"><label>17</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ikeda</surname><given-names>M</given-names></name><name><surname>Watarai</surname><given-names>K</given-names></name><name><surname>Suzuki</surname><given-names>M</given-names></name><name><surname>Ito</surname><given-names>T</given-names></name><name><surname>Yamasaki</surname><given-names>H</given-names></name><name><surname>Sagai</surname><given-names>M</given-names></name><name><surname>Tomita</surname><given-names>T</given-names></name></person-group>
<article-title>Mechanism of pathophysiological effects of diesel exhaust particles on endothelial cells</article-title>. <source>Environ Toxicol Pharmacol</source>. <year>1998</year>;
<volume>6</volume>:<fpage>117</fpage>-<lpage>123</lpage><pub-id pub-id-type="pmid">21781888</pub-id></mixed-citation></ref><ref id="b18"><label>18</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moncada</surname><given-names>S</given-names></name><name><surname>Higgs</surname><given-names>A</given-names></name></person-group>
<article-title>The l&#x02010;arginine&#x02010;nitric oxide pathway</article-title>. <source>N Engl J Med</source>. <year>1993</year>;
<volume>329</volume>:<fpage>2002</fpage>-<lpage>2012</lpage><pub-id pub-id-type="pmid">7504210</pub-id></mixed-citation></ref><ref id="b19"><label>19</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Verma</surname><given-names>S</given-names></name><name><surname>Anderson</surname><given-names>TJ</given-names></name></person-group>
<article-title>Fundamentals of endothelial function for the clinical cardiologist</article-title>. <source>Circulation</source>. <year>2002</year>;
<volume>105</volume>:<fpage>546</fpage>-<lpage>549</lpage><pub-id pub-id-type="pmid">11827916</pub-id></mixed-citation></ref><ref id="b20"><label>20</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nurkiewicz</surname><given-names>TR</given-names></name><name><surname>Porter</surname><given-names>DW</given-names></name><name><surname>Hubbs</surname><given-names>AF</given-names></name><name><surname>Stone</surname><given-names>S</given-names></name><name><surname>Chen</surname><given-names>BT</given-names></name><name><surname>Frazer</surname><given-names>DG</given-names></name><name><surname>Boegehold</surname><given-names>MA</given-names></name><name><surname>Castranova</surname><given-names>V</given-names></name></person-group>
<article-title>Pulmonary nanoparticle exposure disrupts systemic microvascular nitric oxide signaling</article-title>. <source>Toxicol Sci</source>. <year>2009</year>;
<volume>110</volume>:<fpage>191</fpage>-<lpage>203</lpage><pub-id pub-id-type="pmid">19270016</pub-id></mixed-citation></ref><ref id="b21"><label>21</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rudell</surname><given-names>B</given-names></name><name><surname>Ledin</surname><given-names>M</given-names></name><name><surname>Hammarstrom</surname><given-names>U</given-names></name><name><surname>Sternberg</surname><given-names>N</given-names></name><name><surname>Lundback</surname><given-names>B</given-names></name><name><surname>Sandstr&#x000f6;m</surname><given-names>T</given-names></name></person-group>
<article-title>Effects on symptoms and lung function in humans experimentally exposed to diesel exhaust</article-title>. <source>Occup Environ Med</source>. <year>1996</year>;
<volume>53</volume>:<fpage>658</fpage>-<lpage>662</lpage><pub-id pub-id-type="pmid">8943829</pub-id></mixed-citation></ref><ref id="b22"><label>22</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Langrish</surname><given-names>JP</given-names></name><name><surname>Lundback</surname><given-names>M</given-names></name><name><surname>Mills</surname><given-names>NL</given-names></name><name><surname>Johnston</surname><given-names>NR</given-names></name><name><surname>Webb</surname><given-names>DJ</given-names></name><name><surname>Sandstrom</surname><given-names>T</given-names></name><name><surname>Blomberg</surname><given-names>A</given-names></name><name><surname>Newby</surname><given-names>DE</given-names></name></person-group>
<article-title>Contribution of endothelin 1 to the vascular effects of diesel exhaust inhalation in humans</article-title>. <source>Hypertension</source>. <year>2009</year>;
<volume>54</volume>:<fpage>910</fpage>-<lpage>915</lpage><pub-id pub-id-type="pmid">19687345</pub-id></mixed-citation></ref><ref id="b23"><label>23</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilkinson</surname><given-names>I</given-names></name><name><surname>Webb</surname><given-names>D</given-names></name></person-group>
<article-title>Venous occlusion plethysmography in cardiovascular research: methodology and clinical applications</article-title>. <source>Br J Clin Pharmacol</source>. <year>2001</year>;
<volume>52</volume>:<fpage>631</fpage>-<lpage>646</lpage><pub-id pub-id-type="pmid">11736874</pub-id></mixed-citation></ref><ref id="b24"><label>24</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Japp</surname><given-names>AG</given-names></name><name><surname>Cruden</surname><given-names>NL</given-names></name><name><surname>Amer</surname><given-names>DA</given-names></name><name><surname>Li</surname><given-names>VK</given-names></name><name><surname>Goudie</surname><given-names>EB</given-names></name><name><surname>Johnston</surname><given-names>NR</given-names></name><name><surname>Sharma</surname><given-names>S</given-names></name><name><surname>Neilson</surname><given-names>I</given-names></name><name><surname>Webb</surname><given-names>DJ</given-names></name><name><surname>Megson</surname><given-names>IL</given-names></name><name><surname>Flapan</surname><given-names>AD</given-names></name><name><surname>Newby</surname><given-names>DE</given-names></name></person-group>
<article-title>Vascular effects of apelin in vivo in man</article-title>. <source>J Am Coll Cardiol</source>. <year>2008</year>;
<volume>52</volume>:<fpage>908</fpage>-<lpage>913</lpage><pub-id pub-id-type="pmid">18772060</pub-id></mixed-citation></ref><ref id="b25"><label>25</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stroes</surname><given-names>ES</given-names></name><name><surname>Luscher</surname><given-names>TF</given-names></name><name><surname>de Groot</surname><given-names>FG</given-names></name><name><surname>Koomans</surname><given-names>HA</given-names></name><name><surname>Rabelink</surname><given-names>TJ</given-names></name></person-group>
<article-title>Cyclosporin a increases nitric oxide activity in vivo</article-title>. <source>Hypertension</source>. <year>1997</year>;
<volume>29</volume>:<fpage>570</fpage>-<lpage>575</lpage><pub-id pub-id-type="pmid">9040440</pub-id></mixed-citation></ref><ref id="b26"><label>26</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haynes</surname><given-names>WG</given-names></name><name><surname>Noon</surname><given-names>JP</given-names></name><name><surname>Walker</surname><given-names>BR</given-names></name><name><surname>Webb</surname><given-names>DJ</given-names></name></person-group>
<article-title>l&#x02010;NMMA increases blood pressure in man</article-title>. <source>Lancet</source>. <year>1993</year>;
<volume>342</volume>:<fpage>931</fpage>-<lpage>932</lpage><pub-id pub-id-type="pmid">8105193</pub-id></mixed-citation></ref><ref id="b27"><label>27</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blackwell</surname><given-names>S</given-names></name><name><surname>O'Reilly</surname><given-names>DS</given-names></name><name><surname>Talwar</surname><given-names>DK</given-names></name></person-group>
<article-title>HPLC analysis of asymmetric dimethylarginine (ADMA) and related arginine metabolites in human plasma using a novel non&#x02010;endogenous internal standard</article-title>. <source>Clin Chim Acta</source>. <year>2009</year>;
<volume>401</volume>:<fpage>14</fpage>-<lpage>19</lpage><pub-id pub-id-type="pmid">19027728</pub-id></mixed-citation></ref><ref id="b28"><label>28</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nagababu</surname><given-names>E</given-names></name><name><surname>Rifkind</surname><given-names>JM</given-names></name></person-group>
<article-title>Measurement of plasma nitrite by chemiluminescence without interference of S&#x02010;, N&#x02010;nitroso and nitrated species</article-title>. <source>Free Radic Biol Med</source>. <year>2007</year>;
<volume>42</volume>:<fpage>1146</fpage>-<lpage>1154</lpage><pub-id pub-id-type="pmid">17382196</pub-id></mixed-citation></ref><ref id="b29"><label>29</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Petrie</surname><given-names>JR</given-names></name><name><surname>Ueda</surname><given-names>S</given-names></name><name><surname>Morris</surname><given-names>AD</given-names></name><name><surname>Murray</surname><given-names>LS</given-names></name><name><surname>Elliott</surname><given-names>HL</given-names></name><name><surname>Connell</surname><given-names>JM</given-names></name></person-group>
<article-title>How reproducible is bilateral forearm plethysmography?</article-title>
<source>Br J Clin Pharmacol</source>. <year>1998</year>;
<volume>45</volume>:<fpage>131</fpage>-<lpage>139</lpage><pub-id pub-id-type="pmid">9491825</pub-id></mixed-citation></ref><ref id="b30"><label>30</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Newby</surname><given-names>D</given-names></name><name><surname>Wright</surname><given-names>R</given-names></name><name><surname>Labinjoh</surname><given-names>C</given-names></name><name><surname>Ludlam</surname><given-names>C</given-names></name><name><surname>Fox</surname><given-names>K</given-names></name><name><surname>Boon</surname><given-names>N</given-names></name><name><surname>Webb</surname><given-names>D</given-names></name></person-group>
<article-title>Endothelial dysfunction, impaired endogenous fibrinolysis, and cigarette smoking: a mechanism for arterial thrombosis and myocardial infarction</article-title>. <source>Circulation</source>. <year>1999</year>;
<volume>99</volume>:<fpage>1411</fpage>-<lpage>1415</lpage><pub-id pub-id-type="pmid">10086962</pub-id></mixed-citation></ref><ref id="b31"><label>31</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barath</surname><given-names>S</given-names></name><name><surname>Mills</surname><given-names>N</given-names></name><name><surname>T&#x000f6;rnqvist</surname><given-names>H</given-names></name><name><surname>Lucking</surname><given-names>A</given-names></name><name><surname>Langrish</surname><given-names>J</given-names></name><name><surname>S&#x000f6;derberg</surname><given-names>S</given-names></name><name><surname>Boman</surname><given-names>C</given-names></name><name><surname>Westerholm</surname><given-names>R</given-names></name><name><surname>L&#x000f6;ndahl</surname><given-names>J</given-names></name><name><surname>Donaldson</surname><given-names>K</given-names></name><name><surname>Sandstr&#x000f6;m</surname><given-names>T</given-names></name><name><surname>Newby</surname><given-names>D</given-names></name><name><surname>Blomberg</surname><given-names>A</given-names></name></person-group>
<article-title>Impaired vascular function after exposure to diesel exhaust generated at urban transient running conditions</article-title>. <source>Part Fibre Toxicol</source>. <year>2010</year>;
<volume>7</volume>:<fpage>19</fpage><pub-id pub-id-type="pmid">20653945</pub-id></mixed-citation></ref><ref id="b32"><label>32</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cirino</surname><given-names>G</given-names></name><name><surname>Fiorucci</surname><given-names>S</given-names></name><name><surname>Sessa</surname><given-names>WC</given-names></name></person-group>
<article-title>Endothelial nitric oxide synthase: the cinderella of inflammation?</article-title>
<source>Trend Pharmacol Sci</source>. <year>2003</year>;
<volume>24</volume>:<fpage>91</fpage>-<lpage>95</lpage></mixed-citation></ref><ref id="b33"><label>33</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kang</surname><given-names>WS</given-names></name><name><surname>Tamarkin</surname><given-names>FJ</given-names></name><name><surname>Wheeler</surname><given-names>MA</given-names></name><name><surname>Weiss</surname><given-names>RM</given-names></name></person-group>
<article-title>Rapid up&#x02010;regulation of endothelial nitric&#x02010;oxide synthase in a mouse model of <italic>Escherichia coli</italic> lipopolysaccharide&#x02010;induced bladder inflammation</article-title>. <source>J Pharmacol Exp Ther</source>. <year>2004</year>;
<volume>310</volume>:<fpage>452</fpage>-<lpage>458</lpage><pub-id pub-id-type="pmid">15082754</pub-id></mixed-citation></ref><ref id="b34"><label>34</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bai</surname><given-names>N</given-names></name><name><surname>Kido</surname><given-names>T</given-names></name><name><surname>Kavanagh</surname><given-names>TJ</given-names></name><name><surname>Kaufman</surname><given-names>JD</given-names></name><name><surname>Rosenfeld</surname><given-names>ME</given-names></name><name><surname>van Breemen</surname><given-names>C</given-names></name><name><surname>van Eeden</surname><given-names>SF</given-names></name></person-group>
<article-title>Exposure to diesel exhaust up&#x02010;regulates inos expression in ApoE knockout mice</article-title>. <source>Toxicol Appl Pharmacol</source>. <year>2011</year>;
<volume>255</volume>:<fpage>184</fpage>-<lpage>192</lpage><pub-id pub-id-type="pmid">21722660</pub-id></mixed-citation></ref><ref id="b35"><label>35</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bai</surname><given-names>N</given-names></name><name><surname>Kido</surname><given-names>T</given-names></name><name><surname>Suzuki</surname><given-names>H</given-names></name><name><surname>Yang</surname><given-names>G</given-names></name><name><surname>Kavanagh</surname><given-names>TJ</given-names></name><name><surname>Kaufman</surname><given-names>JD</given-names></name><name><surname>Rosenfeld</surname><given-names>ME</given-names></name><name><surname>van Breemen</surname><given-names>C</given-names></name><name><surname>Eeden</surname><given-names>SF</given-names></name></person-group>
<article-title>Changes in atherosclerotic plaques induced by inhalation of diesel exhaust</article-title>. <source>Atherosclerosis</source>. <year>2011</year>;
<volume>216</volume>:<fpage>299</fpage>-<lpage>306</lpage><pub-id pub-id-type="pmid">21435644</pub-id></mixed-citation></ref><ref id="b36"><label>36</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miller</surname><given-names>MR</given-names></name><name><surname>Borthwick</surname><given-names>SJ</given-names></name><name><surname>Shaw</surname><given-names>CA</given-names></name><name><surname>McLean</surname><given-names>SG</given-names></name><name><surname>McClure</surname><given-names>D</given-names></name><name><surname>Mills</surname><given-names>NL</given-names></name><name><surname>Duffin</surname><given-names>R</given-names></name><name><surname>Donaldson</surname><given-names>K</given-names></name><name><surname>Megson</surname><given-names>IL</given-names></name><name><surname>Hadoke</surname><given-names>PW</given-names></name><name><surname>Newby</surname><given-names>DE</given-names></name></person-group>
<article-title>Direct impairment of vascular function by diesel exhaust particulate through reduced bioavailability of endothelium&#x02010;derived nitric oxide induced by superoxide free radicals</article-title>. <source>Environ Health Perspect</source>. <year>2009</year>;
<volume>117</volume>:<fpage>611</fpage>-<lpage>616</lpage><pub-id pub-id-type="pmid">19440501</pub-id></mixed-citation></ref><ref id="b37"><label>37</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Knuckles</surname><given-names>TL</given-names></name><name><surname>Lund</surname><given-names>AK</given-names></name><name><surname>Lucas</surname><given-names>SN</given-names></name><name><surname>Campen</surname><given-names>MJ</given-names></name></person-group>
<article-title>Diesel exhaust exposure enhances venoconstriction via uncoupling of eNOS</article-title>. <source>Toxicol Appl Pharmacol</source>. <year>2008</year>;
<volume>230</volume>:<fpage>346</fpage>-<lpage>351</lpage><pub-id pub-id-type="pmid">18455212</pub-id></mixed-citation></ref><ref id="b38"><label>38</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Knuckles</surname><given-names>TL</given-names></name><name><surname>Buntz</surname><given-names>JG</given-names></name><name><surname>Paffett</surname><given-names>M</given-names></name><name><surname>Channell</surname><given-names>M</given-names></name><name><surname>Harmon</surname><given-names>M</given-names></name><name><surname>Cherng</surname><given-names>T</given-names></name><name><surname>Lucas</surname><given-names>SN</given-names></name><name><surname>McDonald</surname><given-names>JD</given-names></name><name><surname>Kanagy</surname><given-names>NL</given-names></name><name><surname>Campen</surname><given-names>MJ</given-names></name></person-group>
<article-title>Formation of vascular S&#x02010;nitrosothiols and plasma nitrates/nitrites following inhalation of diesel emissions</article-title>. <source>J Toxicol Environ Health A</source>. <year>2011</year>;
<volume>74</volume>:<fpage>828</fpage>-<lpage>837</lpage><pub-id pub-id-type="pmid">21598168</pub-id></mixed-citation></ref><ref id="b39"><label>39</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Munzel</surname><given-names>T</given-names></name><name><surname>Gori</surname><given-names>T</given-names></name><name><surname>Bruno</surname><given-names>RM</given-names></name><name><surname>Taddei</surname><given-names>S</given-names></name></person-group>
<article-title>Is oxidative stress a therapeutic target in cardiovascular disease?</article-title>
<source>Eur Heart J</source>. <year>2010</year>;
<volume>31</volume>:<fpage>2741</fpage>-<lpage>2748</lpage><pub-id pub-id-type="pmid">20974801</pub-id></mixed-citation></ref><ref id="b40"><label>40</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brook</surname><given-names>RD</given-names></name><name><surname>Rajagopalan</surname><given-names>S</given-names></name><name><surname>Pope</surname><given-names>CA</given-names><suffix>III</suffix></name><name><surname>Brook</surname><given-names>JR</given-names></name><name><surname>Bhatnagar</surname><given-names>A</given-names></name><name><surname>Diez&#x02010;Roux</surname><given-names>AV</given-names></name><name><surname>Holguin</surname><given-names>F</given-names></name><name><surname>Hong</surname><given-names>Y</given-names></name><name><surname>Luepker</surname><given-names>RV</given-names></name><name><surname>Mittleman</surname><given-names>MA</given-names></name><name><surname>Peters</surname><given-names>A</given-names></name><name><surname>Siscovick</surname><given-names>D</given-names></name><name><surname>Smith</surname><given-names>SC</given-names><suffix>Jr</suffix></name><name><surname>Whitsel</surname><given-names>L</given-names></name><name><surname>Kaufman</surname><given-names>JD</given-names></name></person-group>
<article-title>Particulate matter air pollution and cardiovascular disease. An update to the scientific statement from the American Heart Association</article-title>. <source>Circulation</source>. <year>2010</year>;
<volume>121</volume>:<fpage>2331</fpage>-<lpage>2378</lpage><pub-id pub-id-type="pmid">20458016</pub-id></mixed-citation></ref><ref id="b41"><label>41</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moller</surname><given-names>P</given-names></name><name><surname>Loft</surname><given-names>S</given-names></name></person-group>
<article-title>Oxidative damage to DNA and lipids as biomarkers of exposure to air pollution</article-title>. <source>Environ Health Perspect</source>. <year>2010</year>;
<volume>118</volume>:<fpage>1126</fpage>-<lpage>1136</lpage><pub-id pub-id-type="pmid">20423813</pub-id></mixed-citation></ref><ref id="b42"><label>42</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Castillo</surname><given-names>L</given-names></name><name><surname>Beaumier</surname><given-names>L</given-names></name><name><surname>Ajami</surname><given-names>AM</given-names></name><name><surname>Young</surname><given-names>VR</given-names></name></person-group>
<article-title>Whole body nitric oxide synthesis in healthy men determined from [15N] arginine&#x02010;to&#x02010;[15N]citrulline labeling</article-title>. <source>Proc Natl Acad Sci USA</source>. <year>1996</year>;
<volume>93</volume>:<fpage>11460</fpage>-<lpage>11465</lpage><pub-id pub-id-type="pmid">8876157</pub-id></mixed-citation></ref><ref id="b43"><label>43</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>G</given-names></name><name><surname>Morris</surname><given-names>SM</given-names><suffix>Jr</suffix></name></person-group>
<article-title>Arginine metabolism: nitric oxide and beyond</article-title>. <source>Biochem J</source>. <year>1998</year>;
<volume>336</volume>:<fpage>1</fpage>-<lpage>17</lpage><pub-id pub-id-type="pmid">9806879</pub-id></mixed-citation></ref><ref id="b44"><label>44</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chowienczyk</surname><given-names>PJ</given-names></name><name><surname>Watts</surname><given-names>GF</given-names></name><name><surname>Cockcroft</surname><given-names>JR</given-names></name><name><surname>Ritter</surname><given-names>JM</given-names></name></person-group>
<article-title>Impaired endothelium&#x02010;dependent vasodilation of forearm resistance vessels in hypercholesterolaemia</article-title>. <source>Lancet</source>. <year>1992</year>;
<volume>340</volume>:<fpage>1430</fpage>-<lpage>1432</lpage><pub-id pub-id-type="pmid">1360559</pub-id></mixed-citation></ref><ref id="b45"><label>45</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Creager</surname><given-names>MA</given-names></name><name><surname>Cooke</surname><given-names>JP</given-names></name><name><surname>Mendelsohn</surname><given-names>ME</given-names></name><name><surname>Gallagher</surname><given-names>SJ</given-names></name><name><surname>Coleman</surname><given-names>SM</given-names></name><name><surname>Loscalzo</surname><given-names>J</given-names></name><name><surname>Dzau</surname><given-names>VJ</given-names></name></person-group>
<article-title>Impaired vasodilation of forearm resistance vessels in hypercholesterolemic humans</article-title>. <source>J Clin Invest</source>. <year>1990</year>;
<volume>86</volume>:<fpage>228</fpage>-<lpage>234</lpage><pub-id pub-id-type="pmid">2195060</pub-id></mixed-citation></ref><ref id="b46"><label>46</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stroes</surname><given-names>ES</given-names></name><name><surname>Koomans</surname><given-names>HA</given-names></name><name><surname>de Bruin</surname><given-names>TW</given-names></name><name><surname>Rabelink</surname><given-names>TJ</given-names></name></person-group>
<article-title>Vascular function in the forearm of hypercholesterolaemic patients off and on lipid&#x02010;lowering medication</article-title>. <source>Lancet</source>. <year>1995</year>;
<volume>346</volume>:<fpage>467</fpage>-<lpage>471</lpage><pub-id pub-id-type="pmid">7637480</pub-id></mixed-citation></ref><ref id="b47"><label>47</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gamboa</surname><given-names>A</given-names></name><name><surname>Shibao</surname><given-names>C</given-names></name><name><surname>Diedrich</surname><given-names>A</given-names></name><name><surname>Choi</surname><given-names>L</given-names></name><name><surname>Pohar</surname><given-names>B</given-names></name><name><surname>Jordan</surname><given-names>J</given-names></name><name><surname>Paranjape</surname><given-names>S</given-names></name><name><surname>Farley</surname><given-names>G</given-names></name><name><surname>Biaggioni</surname><given-names>I</given-names></name></person-group>
<article-title>Contribution of endothelial nitric oxide to blood pressure in humans</article-title>. <source>Hypertension</source>. <year>2007</year>;
<volume>49</volume>:<fpage>170</fpage>-<lpage>177</lpage><pub-id pub-id-type="pmid">17130304</pub-id></mixed-citation></ref><ref id="b48"><label>48</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haynes</surname><given-names>WG</given-names></name><name><surname>Noon</surname><given-names>JP</given-names></name><name><surname>Walker</surname><given-names>BR</given-names></name><name><surname>Webb</surname><given-names>DJ</given-names></name></person-group>
<article-title>Inhibition of nitric oxide synthesis increases blood pressure in healthy humans</article-title>. <source>J Hypertens</source>. <year>1993</year>;
<volume>11</volume>:<fpage>1375</fpage>-<lpage>1380</lpage><pub-id pub-id-type="pmid">7510736</pub-id></mixed-citation></ref><ref id="b49"><label>49</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rassaf</surname><given-names>T</given-names></name><name><surname>Poll</surname><given-names>LW</given-names></name><name><surname>Brouzos</surname><given-names>P</given-names></name><name><surname>Lauer</surname><given-names>T</given-names></name><name><surname>Totzeck</surname><given-names>M</given-names></name><name><surname>Kleinbongard</surname><given-names>P</given-names></name><name><surname>Gharini</surname><given-names>P</given-names></name><name><surname>Andersen</surname><given-names>K</given-names></name><name><surname>Schulz</surname><given-names>R</given-names></name><name><surname>Heusch</surname><given-names>G</given-names></name><name><surname>Modder</surname><given-names>U</given-names></name><name><surname>Kelm</surname><given-names>M</given-names></name></person-group>
<article-title>Positive effects of nitric oxide on left ventricular function in humans</article-title>. <source>Eur Heart J</source>. <year>2006</year>;
<volume>27</volume>:<fpage>1699</fpage>-<lpage>1705</lpage><pub-id pub-id-type="pmid">16782717</pub-id></mixed-citation></ref><ref id="b50"><label>50</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stewart</surname><given-names>AD</given-names></name><name><surname>Millasseau</surname><given-names>SC</given-names></name><name><surname>Kearney</surname><given-names>MT</given-names></name><name><surname>Ritter</surname><given-names>JM</given-names></name><name><surname>Chowienczyk</surname><given-names>PJ</given-names></name></person-group>
<article-title>Effects of inhibition of basal nitric oxide synthesis on carotid&#x02010;femoral pulse wave velocity and augmentation index in humans</article-title>. <source>Hypertension</source>. <year>2003</year>;
<volume>42</volume>:<fpage>915</fpage>-<lpage>918</lpage><pub-id pub-id-type="pmid">12975386</pub-id></mixed-citation></ref><ref id="b51"><label>51</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilkinson</surname><given-names>IB</given-names></name><name><surname>MacCallum</surname><given-names>H</given-names></name><name><surname>Cockcroft</surname><given-names>JR</given-names></name><name><surname>Webb</surname><given-names>DJ</given-names></name></person-group>
<article-title>Inhibition of basal nitric oxide synthesis increases aortic augmentation index and pulse wave velocity in vivo</article-title>. <source>Br J Clin Pharmacol</source>. <year>2002</year>;
<volume>53</volume>:<fpage>189</fpage>-<lpage>192</lpage><pub-id pub-id-type="pmid">11851643</pub-id></mixed-citation></ref><ref id="b52"><label>52</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Corretti</surname><given-names>MC</given-names></name><name><surname>Anderson</surname><given-names>TJ</given-names></name><name><surname>Benjamin</surname><given-names>EJ</given-names></name><name><surname>Celermajer</surname><given-names>D</given-names></name><name><surname>Charbonneau</surname><given-names>F</given-names></name><name><surname>Creager</surname><given-names>MA</given-names></name><name><surname>Deanfield</surname><given-names>J</given-names></name><name><surname>Drexler</surname><given-names>H</given-names></name><name><surname>Gerhard&#x02010;Herman</surname><given-names>M</given-names></name><name><surname>Herrington</surname><given-names>D</given-names></name><name><surname>Vallance</surname><given-names>P</given-names></name><name><surname>Vita</surname><given-names>J</given-names></name><name><surname>Vogel</surname><given-names>R</given-names></name></person-group>
<article-title>Guidelines for the ultrasound assessment of endothelial&#x02010;dependent flow&#x02010;mediated vasodilation of the brachial artery: a report of the international brachial artery reactivity task force</article-title>. <source>J Am Coll Cardiol</source>. <year>2002</year>;
<volume>39</volume>:<fpage>257</fpage>-<lpage>265</lpage><pub-id pub-id-type="pmid">11788217</pub-id></mixed-citation></ref><ref id="b53"><label>53</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luksha</surname><given-names>L</given-names></name><name><surname>Agewall</surname><given-names>S</given-names></name><name><surname>Kublickiene</surname><given-names>K</given-names></name></person-group>
<article-title>Endothelium&#x02010;derived hyperpolarizing factor in vascular physiology and cardiovascular disease</article-title>. <source>Atherosclerosis</source>. <year>2009</year>;
<volume>202</volume>:<fpage>330</fpage>-<lpage>344</lpage><pub-id pub-id-type="pmid">18656197</pub-id></mixed-citation></ref><ref id="b54"><label>54</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tomioka</surname><given-names>H</given-names></name><name><surname>Hattori</surname><given-names>Y</given-names></name><name><surname>Fukao</surname><given-names>M</given-names></name><name><surname>Sato</surname><given-names>A</given-names></name><name><surname>Liu</surname><given-names>M</given-names></name><name><surname>Sakuma</surname><given-names>I</given-names></name><name><surname>Kitabatake</surname><given-names>A</given-names></name><name><surname>Kanno</surname><given-names>M</given-names></name></person-group>
<article-title>Relaxation in different&#x02010;sized rat blood vessels mediated by endothelium&#x02010;derived hyperpolarizing factor: importance of processes mediating precontractions</article-title>. <source>J Vasc Res</source>. <year>1999</year>;
<volume>36</volume>:<fpage>311</fpage>-<lpage>320</lpage><pub-id pub-id-type="pmid">10474044</pub-id></mixed-citation></ref><ref id="b55"><label>55</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brook</surname><given-names>RD</given-names></name><name><surname>Urch</surname><given-names>B</given-names></name><name><surname>Dvonch</surname><given-names>JT</given-names></name><name><surname>Bard</surname><given-names>RL</given-names></name><name><surname>Speck</surname><given-names>M</given-names></name><name><surname>Keeler</surname><given-names>G</given-names></name><name><surname>Morishita</surname><given-names>M</given-names></name><name><surname>Marsik</surname><given-names>FJ</given-names></name><name><surname>Kamal</surname><given-names>AS</given-names></name><name><surname>Kaciroti</surname><given-names>N</given-names></name><name><surname>Harkema</surname><given-names>J</given-names></name><name><surname>Corey</surname><given-names>P</given-names></name><name><surname>Silverman</surname><given-names>F</given-names></name><name><surname>Gold</surname><given-names>DR</given-names></name><name><surname>Wellenius</surname><given-names>G</given-names></name><name><surname>Mittleman</surname><given-names>MA</given-names></name><name><surname>Rajagopalan</surname><given-names>S</given-names></name><name><surname>Brook</surname><given-names>JR</given-names></name></person-group>
<article-title>Insights into the mechanisms and mediators of the effects of air pollution exposure on blood pressure and vascular function in healthy humans</article-title>. <source>Hypertension</source>. <year>2009</year>;
<volume>54</volume>:<fpage>659</fpage>-<lpage>667</lpage><pub-id pub-id-type="pmid">19620518</pub-id></mixed-citation></ref><ref id="b56"><label>56</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Auchincloss</surname><given-names>AH</given-names></name><name><surname>Roux</surname><given-names>AV</given-names></name><name><surname>Dvonch</surname><given-names>JT</given-names></name><name><surname>Brown</surname><given-names>PL</given-names></name><name><surname>Barr</surname><given-names>RG</given-names></name><name><surname>Daviglus</surname><given-names>ML</given-names></name><name><surname>Goff</surname><given-names>DC</given-names></name><name><surname>Kaufman</surname><given-names>JD</given-names></name><name><surname>O'Neill</surname><given-names>MS</given-names></name></person-group>
<article-title>Associations between recent exposure to ambient fine particulate matter and blood pressure in the multi&#x02010;ethnic study of atherosclerosis (MESA)</article-title>. <source>Environ Health Perspect</source>. <year>2008</year>;
<volume>116</volume>:<fpage>486</fpage>-<lpage>491</lpage><pub-id pub-id-type="pmid">18414631</pub-id></mixed-citation></ref><ref id="b57"><label>57</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gold</surname><given-names>D</given-names></name><name><surname>Litonjua</surname><given-names>A</given-names></name><name><surname>Schwartz</surname><given-names>J</given-names></name><name><surname>Lovett</surname><given-names>E</given-names></name><name><surname>Larson</surname><given-names>A</given-names></name><name><surname>Nearing</surname><given-names>B</given-names></name><name><surname>Allen</surname><given-names>G</given-names></name><name><surname>Verrier</surname><given-names>M</given-names></name><name><surname>Cherry</surname><given-names>R</given-names></name><name><surname>Verrier</surname><given-names>R</given-names></name></person-group>
<article-title>Ambient pollution and heart rate variability</article-title>. <source>Circulation</source>. <year>2000</year>;
<volume>101</volume>:<fpage>1267</fpage>-<lpage>1273</lpage><pub-id pub-id-type="pmid">10725286</pub-id></mixed-citation></ref></ref-list></back></article>